Follow us on:

Linkedin Facebook

FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Smiths Group plc

Smiths Group Plc delivers strong financial results, reaffirms full year guidance

Smiths Group plc reports robust half-year results, showcasing strong revenue growth, margin expansion, and strategic actions to enhance shareholder value...
SEGRO

SEGRO Plc and Pure DC create JV to develop its first fully fitted data centre

SEGRO Plc and Pure Data Centres Group have formed a £1bn joint venture to develop a state-of-the-art data centre in London, aiming to meet growing digital needs...
Kingfisher plc

Kingfisher Plc grows market share in all key regions

Kingfisher Plc's final results for the year ending January 31, 2025, reveal strategic growth and market share gains across key regions. Read on for insights...
Intertek Group

Intertek Group Plc commences Share buyback programme

Intertek Group Plc launches a share buyback program valued up to £350 million, aimed at reducing company capital while adhering to AGM authority...
Airtel Africa

Airtel Africa Plc appoints Cynthia Gordon as an independent non-executive director

Airtel Africa appoints Cynthia Gordon as an independent non-executive director, enhancing its board with her extensive telecommunications expertise across Africa...
GSK

GSK Plc Nucala application for COPD accepted by EMA

GSK announces the EMA's review of Nucala (mepolizumab) as a potential add-on treatment for COPD, promising hope for 40 million patients battling this condition...
GSK

Haleon Plc publishes 2024 Annual Report

Haleon plc has released its Annual Report for 2024, detailing vital financial information and upcoming AGM plans. Discover key insights for investors now...
Londonmetric Property

LondonMetric Property Plc assigned BBB+ by Fitch Ratings

LondonMetric Property Plc has received a 'BBB+' Long-Term Issuer Default Rating from Fitch Ratings, enhancing its financial position and future financing options...
M&G plc

M&G Plc reports operating profit up 5%, resilient capital generation

M&G plc reveals promising results for 2024, showcasing a new dividend policy with a 2% increase and strong financial performance, signaling robust growth potential...

F&C Investment Trust Plc NAV total return of +21.0%, beating benchmark

F&C Investment Trust plc (LON:FCIT) reports impressive annual results for 2024, showcasing strong shareholder returns and a consistent investment strategy...
AstraZeneca

AstraZeneca Plc advances cell therapy ambition, acquiring EsoBiotec

AstraZeneca is set to transform cancer treatment by acquiring EsoBiotec, a leader in in vivo cell therapies that promise quicker, more effective patient care...
Berkeley Group Holdings plc

Berkeley Group maintains its strong financial position, reaffirms earnings guidance

Berkeley Group Holdings plc announces its trading update, outlining a strong profit outlook and strategic growth plans amid evolving market conditions...
Howdens Joinery

Howden Joinery Group Plc £100 million share buy-back programme

Howden Joinery Group Plc plans to repurchase shares valued at £100 million, starting with £50 million from March 2025, aiming to enhance shareholder value...
Halma plc

Halma Plc reports good progress in H2, margin guidance higher for FY

Halma Plc (LON:HLMA) reports steady growth ahead of its financial year-end, with improved margin guidance and a strong acquisition pipeline...
Legal & General

Legal & General Group Plc delivers strong financial performance, enhanced returns

Legal & General Group Plc reports a robust 6% growth in core operating profit for 2024, highlighting strategic progress and plans for a £500 million buyback...
Spirax-Sarco Engineering

Spirax Group Plc declares final dividend of 117.5 pence per share

Spirax Group plc proposes a final dividend of 117.5 pence per share for 2024, subject to shareholder approval, enhancing total dividends to 165.0 pence for the year...
Spirax Group

Spirax Group Plc FY revenue down, confident of organic sales growth well ahead of IP

Spirax Group Plc reports strong 2024 full-year results with 4% organic growth and improved margins, showcasing resilience in a challenging market...
Persimmon Plc

Persimmon Plc delivered increases in completions, outlets and profit in FY24

Persimmon Plc (LON:PSN) reveals impressive 2024 results, showcasing a 7% rise in new home completions and significant growth in profits and revenue...

Alliance Witan Plc reports a landmark year, strong outright gains for shareholders

Alliance Witan Plc (LON:ALW) reports strong annual results for 2024, highlighted by its promotion to the FTSE 100 and a continued dividend increase for shareholders...
intravenous (IV) line

AstraZeneca Plc Imfinzi demonstrates improved EFS in early stage gastric cancer

The MATTERHORN Phase III trial reveals promising results for AstraZeneca's Imfinzi in enhancing event-free survival for patients with early-stage gastric cancer...

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Interviews

Smiths Group plc

Smiths Group Plc delivers strong financial results, reaffirms full year guidance

Smiths Group plc reports robust half-year results, showcasing strong revenue growth, margin expansion, and strategic actions to enhance shareholder value...
SEGRO

SEGRO Plc and Pure DC create JV to develop its first fully fitted data centre

SEGRO Plc and Pure Data Centres Group have formed a £1bn joint venture to develop a state-of-the-art data centre in London, aiming to meet growing digital needs...
Kingfisher plc

Kingfisher Plc grows market share in all key regions

Kingfisher Plc's final results for the year ending January 31, 2025, reveal strategic growth and market share gains across key regions. Read on for insights...
Intertek Group

Intertek Group Plc commences Share buyback programme

Intertek Group Plc launches a share buyback program valued up to £350 million, aimed at reducing company capital while adhering to AGM authority...
Airtel Africa

Airtel Africa Plc appoints Cynthia Gordon as an independent non-executive director

Airtel Africa appoints Cynthia Gordon as an independent non-executive director, enhancing its board with her extensive telecommunications expertise across Africa...
GSK

GSK Plc Nucala application for COPD accepted by EMA

GSK announces the EMA's review of Nucala (mepolizumab) as a potential add-on treatment for COPD, promising hope for 40 million patients battling this condition...
GSK

Haleon Plc publishes 2024 Annual Report

Haleon plc has released its Annual Report for 2024, detailing vital financial information and upcoming AGM plans. Discover key insights for investors now...
Londonmetric Property

LondonMetric Property Plc assigned BBB+ by Fitch Ratings

LondonMetric Property Plc has received a 'BBB+' Long-Term Issuer Default Rating from Fitch Ratings, enhancing its financial position and future financing options...
M&G plc

M&G Plc reports operating profit up 5%, resilient capital generation

M&G plc reveals promising results for 2024, showcasing a new dividend policy with a 2% increase and strong financial performance, signaling robust growth potential...

F&C Investment Trust Plc NAV total return of +21.0%, beating benchmark

F&C Investment Trust plc (LON:FCIT) reports impressive annual results for 2024, showcasing strong shareholder returns and a consistent investment strategy...
AstraZeneca

AstraZeneca Plc advances cell therapy ambition, acquiring EsoBiotec

AstraZeneca is set to transform cancer treatment by acquiring EsoBiotec, a leader in in vivo cell therapies that promise quicker, more effective patient care...
Berkeley Group Holdings plc

Berkeley Group maintains its strong financial position, reaffirms earnings guidance

Berkeley Group Holdings plc announces its trading update, outlining a strong profit outlook and strategic growth plans amid evolving market conditions...
Howdens Joinery

Howden Joinery Group Plc £100 million share buy-back programme

Howden Joinery Group Plc plans to repurchase shares valued at £100 million, starting with £50 million from March 2025, aiming to enhance shareholder value...
Halma plc

Halma Plc reports good progress in H2, margin guidance higher for FY

Halma Plc (LON:HLMA) reports steady growth ahead of its financial year-end, with improved margin guidance and a strong acquisition pipeline...
Legal & General

Legal & General Group Plc delivers strong financial performance, enhanced returns

Legal & General Group Plc reports a robust 6% growth in core operating profit for 2024, highlighting strategic progress and plans for a £500 million buyback...
Spirax-Sarco Engineering

Spirax Group Plc declares final dividend of 117.5 pence per share

Spirax Group plc proposes a final dividend of 117.5 pence per share for 2024, subject to shareholder approval, enhancing total dividends to 165.0 pence for the year...
Spirax Group

Spirax Group Plc FY revenue down, confident of organic sales growth well ahead of IP

Spirax Group Plc reports strong 2024 full-year results with 4% organic growth and improved margins, showcasing resilience in a challenging market...
Persimmon Plc

Persimmon Plc delivered increases in completions, outlets and profit in FY24

Persimmon Plc (LON:PSN) reveals impressive 2024 results, showcasing a 7% rise in new home completions and significant growth in profits and revenue...

Alliance Witan Plc reports a landmark year, strong outright gains for shareholders

Alliance Witan Plc (LON:ALW) reports strong annual results for 2024, highlighted by its promotion to the FTSE 100 and a continued dividend increase for shareholders...
intravenous (IV) line

AstraZeneca Plc Imfinzi demonstrates improved EFS in early stage gastric cancer

The MATTERHORN Phase III trial reveals promising results for AstraZeneca's Imfinzi in enhancing event-free survival for patients with early-stage gastric cancer...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

FTSE 100

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple